Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can range from $0 a month to over $1,000 if it isn't covered.
Should the government play a role in setting the price of prescription drugs in our country? To some degree it's already happening for some Medicare recipients beginning in 2026. But that involvement is not guaranteed to last and it is very much contingent on the outcome of this election.Lawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can range from $0 a month to over $1,000 if it isn't covered.
Medicare is negotiating drug prices. Here's why that mattersBut should the government play an even larger role? On Tuesday the CEO of Novo Nordisk, the maker of popular diabetes and weight loss drugs Ozempic and Wegovy, goes before the Senate Health Committee.A report produced by that committee earlier this year found the company was charging Americans with Type 2 diabetes $969 a month for Ozempic, while the same exact drug can be purchased for just $59 in Germany.
Medicare will expand to cover more mental health needs in 2024
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic vs Wegovy: The Risks And Side Effects of Semaglutide DrugsThe Best in Science News and Amazing Breakthroughs
Read more »
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies FindNew trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways.
Read more »
How Ozempic, Wegovy, Mounjaro, Zepbound May Help Treat Other Diseases: Here’s What To KnowArianna Johnson is a reporter on the Forbes news desk who covers explainers and trends, with a frequent focus on health and science. She joined Forbes in 2022 and works in Texas. Johnson has covered prominent weight loss drugs like Ozempic and Wegovy, the health effects of the artificial sweetener aspartame and the impacts of the Covid vaccines.
Read more »
Pennsylvania mom Juanita Gantt files lawsuit against drugmaker claiming Ozempic and Wegovy nearly killed herToday's Video Headlines: 9/4/24
Read more »
Experimental Weight Loss Drug Beat Ozempic and Wegovy in Early TrialPeople taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the average weight loss seen with semaglutide.
Read more »
Ahead of Novo Nordisk Hearing, 250 Clinicians Demand Affordable Access to Ozempic and WegovyNewswire Editor is a Common Dreams staff position.
Read more »